It beggars belief that Neuren would sign off on an agreement which is tantamount to commercial suicide if they have no agency over what they can do. Undoubtedly I'm not an expert on contracts, but it seems to me that some folks picture Neuren as the minnow where I see them as equal.
The JSC was designed to ensure one party does not outmanoeuvre another, the agreement was negotiated in good faith, Jon and Neuren don't seem particularly worried about how events are unfolding so far yet shareholders here appear to be splitting hairs over legalese (and I say this with all due respect to fellow posters).
Neuren is conducting preclinical studies in undisclosed indications for competitive reasons. Are they competing with Acadia? Have they had discussions with Acadia about said undisclosed indications already and Acadia have given an assurance they will not impede Neuren's progress? It would be beyond bizarre if Neuren did these studies and all of a sudden Acadia says no. Would Neuren pigeonhole themselves like this and put themselves under the boot of Acadia? I really hope that's not the case and I don't think Neuren is that foolish.
IMO I think there's an understanding between the companies we are not privy to, of which I think the PR voucher has some part to play. What is Acadia waiting for?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)